Skip to main content

1 Result(s)

within Jean Darloy Remove this filter

and

  1. Article

    Open Access

    Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

    The main objective of this work was to assess the maintenance of effectiveness of subcutaneous tocilizumab 6 months after switching from intravenous to subcutaneous formulation in patients with rheumatoid arth...

    Jean Darloy, Nicolas Segaud, Jean-Hugues Salmon… in Rheumatology and Therapy (2019)

    Download PDF (759 KB) View Article